Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER2-positive early-stage breast cancer: a retrospective study

Hang Lu, Han Yan, Shichong Liao, Jingwen Deng, Jiucheng Zhang, Feng Yao, Hongmei Zheng, Shengrong Sun, Yimin Zhang